Send the following on WhatsApp
Continue to ChatEfficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial - https://avesis.hacettepe.edu.tr/yayin/a283bd9f-b4e6-465e-9d5a-066aa0c228f9/efficacy-immunogenicity-and-safety-of-the-two-dose-schedules-of-turkovac-versus-coronavac-in-healthy-subjects-a-randomized-observer-blinded-non-inferiority-phase-iii-trial